28
Clinical Guidelines—Aspirin Use for the Prevention of Cardiovascular Disease

D4 Asprin Therapy

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: D4  Asprin Therapy

Clinical Guidelines—Aspirin Use for the Prevention of Cardiovascular Disease

Page 2: D4  Asprin Therapy

2

Heart Disease and StrokeBackground

Heart disease and stroke are two of the leading causes of death in the United States.

Americans suffer more than 2 million heart attacks

and strokes each year.

Page 3: D4  Asprin Therapy

3

Heart Disease and StrokeRisk Factors

Approximately 49% of adults have at least one major risk factor for heart disease and stroke.

(Source: www.cdc.gov/heartdisease/facts.htm 3/23/12)

Page 4: D4  Asprin Therapy

4

Heart Disease and StrokeMortality Rates by Ethnicity

(Source: http://www.cdc.gov/heartdisease/facts.htm 3/23/12)

Page 5: D4  Asprin Therapy

5

Aspirin TherapyBenefits

The U.S. Preventive Services Task Force (USPSTF) found good evidence that aspirin decreases the incidence of myocardial infarction in men and ischemic strokes in women.

However…the USPSTF also found good evidence that aspirin increases the incidence of gastrointestinal bleeding and fair evidence that aspirin increases the incidence of hemorrhagic stroke.

Page 6: D4  Asprin Therapy

6

Aspirin TherapyBenefits

The benefits of aspirin therapy depend substantially on an individual’s risk of cardiovascular disease or stroke and adverse treatment effects.

Page 7: D4  Asprin Therapy

7

Aspirin TherapyBenefits

Understanding who benefits from aspirin use, and how much, can help clinicians and patients develop a more patient-centered approach to preventive therapy.

Page 8: D4  Asprin Therapy

8

Aspirin TherapyClinical Guidelines

The USPSTF recommends aspirin therapy for

Page 9: D4  Asprin Therapy

9

Aspirin TherapyClinical Guidelines

According to the USPSTF,

Page 10: D4  Asprin Therapy

10

Aspirin TherapyRisk of GI Bleeding

Age: Increases with age—with or without aspirin therapy

Gender: Twice the risk for men

Page 11: D4  Asprin Therapy

11

Aspirin TherapyRisk of GI Bleeding

GI Ulcers: 2 to 3 times greater in patients with history of GI ulcers

Non-SteroidalAnti-inflammatoryDrug (NSAID) Use:

Quadruples risk for serious GI bleeding compared to aspirin use alone

Other Factors: History or presence of upper GI tract pain, uncontrolled hypertension, and concomitant use of anticoagulants

Page 12: D4  Asprin Therapy

12

Aspirin Therapy - MenBenefit vs Risk

The net benefit of aspirintherapy for men depends on

• the initial risk for coronary heart disease (CHD) events and

• GI bleeding.

Page 13: D4  Asprin Therapy

13

Aspirin Therapy - MenRisk Factors for CHD

Page 14: D4  Asprin Therapy

14

Aspirin Therapy - MenRisk Factors for CHD

Tools to determine individual risk for CHD

National Cholesterol Education Program

Million Hearts

Page 15: D4  Asprin Therapy

15

Aspirin Therapy - WomenBenefit vs Risk

The net benefit of aspirintherapy for womendepends on• the initial risk for stroke and• GI bleeding.

Page 16: D4  Asprin Therapy

16

WomenRisk Factors for Stroke

Page 17: D4  Asprin Therapy

17

Aspirin Therapy - WomenRisk Factors for Stroke

Tools to determine individual risk for stroke

Personal StrokeRisk

Page 18: D4  Asprin Therapy

18

Aspirin TherapyWeighing Benefits

Ultimately, aspirin therapy is the patient’s choice.

Page 19: D4  Asprin Therapy

19

Aspirin TherapyWeighing Benefits

Estimated heart attacksprevented and estimatedharms of using aspirin for10 years in a hypotheticalcohort of 1000 men aged45-79 years.

(Source: http://www.uspreventiveservicetaskforce.org/uspstf09/aspirincvd.aspcvdrsf2.htm)

Page 20: D4  Asprin Therapy

20

Aspirin TherapyWeighing Benefits

(Source: http://www.uspreventiveservicestaskforce.org/uspstf09/aspirincvd/aspcvdrsf4.htm)

Estimated number ofstrokes preventedaccording to the strokerisk level in women aged45 to 79 years.

Page 21: D4  Asprin Therapy

21

Aspirin TherapyWeighing Benefits

Those with a high likelihood of benefiting with little potential for harm should be encouraged to consider aspirin.

Page 22: D4  Asprin Therapy

22

Aspirin TherapyWeighing Benefits

Aspirin should be discouraged

among those with little potential of benefiting or ahigh risk of GI bleeding.

Page 23: D4  Asprin Therapy

23

Aspirin TherapyWeighing Benefits

Some might decide thatavoiding a heart attack orstroke is of greater value thanhaving GI bleeding.

Page 24: D4  Asprin Therapy

24

Aspirin TherapyWeighing Benefits

Encourage shared decision-making with those whose potential benefits and risks for serious GI bleeding are more closely balanced.

Page 25: D4  Asprin Therapy

25

Aspirin TherapyDose/Dosage

According to USPSTF• The optimum dose of aspirin for preventing

cardiovascular disease events and stroke is unknown.

• Primary prevention trials have shown benefits with various regimens.

• Approximately 75 mg/d aspirin seems as effective as higher dosages.

Page 26: D4  Asprin Therapy

26

Remember

Understanding who benefits from aspirin use, and how much, can help clinicians and patients develop a more patient-centered approach to preventive therapy.

Page 27: D4  Asprin Therapy

27

Questions/Comments?

Sandy [email protected]

Page 28: D4  Asprin Therapy

28

Resources

U.S. Preventative Services Task Force (USPSTF)Aspirin for the Prevention of Cardiovascular Disease

Centers for Disease ControlRecommendations for Aspirin for Prevention of Cardiovascular Disease

Million Hearts

PubMed.gov Individual and Population Benefits of Daily Aspirin Therapy: a Proposal for Personalizing National Guidelines